Tristel Cash Flow Conversion Efficiency

Latest as of December 2025: 0.161x

Tristel cash flow conversion efficiency. Based on the latest financial reports, Tristel (TSTL) has a cash flow conversion efficiency ratio of 0.161x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX5.41 Million ≈ $657.75 USD) by net assets (GBX33.55 Million ≈ $4.08K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Tristel (2004–2025)

Cash flow conversion efficiency of Tristel from 2004 to 2025. This chart illustrates how Tristel's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Tristel stock price for real-time trading data and today's change.

Tristel Cash Flow Conversion Ratio Explained

Tristel cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Tristel Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tristel ranked by their cash flow conversion efficiency. Also see TSTL market cap overview for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Yowie Group Ltd
AU:YOW
-0.091x
Nobel29 Resources Corp
V:NBLC
0.055x
TECH INVEST GROUP ZY-02
F:6N2
0.044x
Plaza Centers NV
WAR:PLZ
0.001x
Streamline Health Solutions Inc
NASDAQ:STRM
-0.088x
Siti Networks Limited
NSE:SITINET
-0.072x
QMC Quantum Minerals Corp
V:QMC
0.001x
Laxmi Cotspin Limited
NSE:LAXMICOT
0.025x

Annual Cash Flow Conversion Efficiency for Tristel (2004–2025)

The table below shows the annual cash flow conversion efficiency of Tristel from 2004 to 2025. Review TSTL free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 GBX32.99 Million
≈ $4.01K
GBX10.32 Million
≈ $1.26K
0.313x -6.90%
2024-06-30 GBX32.41 Million
≈ $3.94K
GBX10.89 Million
≈ $1.32K
0.336x +21.39%
2023-06-30 GBX30.68 Million
≈ $3.73K
GBX8.49 Million
≈ $1.03K
0.277x +44.43%
2022-06-30 GBX28.99 Million
≈ $3.53K
GBX5.55 Million
≈ $675.64
0.192x -11.04%
2021-06-30 GBX30.08 Million
≈ $3.66K
GBX6.48 Million
≈ $788.19
0.215x -12.30%
2020-06-30 GBX28.46 Million
≈ $3.46K
GBX6.99 Million
≈ $850.36
0.246x +4.55%
2019-06-30 GBX23.36 Million
≈ $2.84K
GBX5.49 Million
≈ $667.49
0.235x -3.72%
2018-06-30 GBX18.43 Million
≈ $2.24K
GBX4.50 Million
≈ $546.91
0.244x -9.97%
2017-06-30 GBX16.06 Million
≈ $1.95K
GBX4.35 Million
≈ $529.51
0.271x -10.89%
2016-06-30 GBX14.96 Million
≈ $1.82K
GBX4.55 Million
≈ $553.60
0.304x +64.89%
2015-06-30 GBX14.16 Million
≈ $1.72K
GBX2.61 Million
≈ $317.80
0.184x -31.92%
2014-06-30 GBX12.08 Million
≈ $1.47K
GBX3.27 Million
≈ $397.99
0.271x +315.55%
2013-06-30 GBX10.88 Million
≈ $1.32K
GBX709.00K
≈ $86.26
0.065x -46.03%
2012-06-30 GBX12.41 Million
≈ $1.51K
GBX1.50 Million
≈ $182.38
0.121x +4897.80%
2011-06-30 GBX11.92 Million
≈ $1.45K
GBX-30.00K
≈ $-3.65
-0.003x -101.73%
2010-06-30 GBX8.49 Million
≈ $1.03K
GBX1.24 Million
≈ $150.26
0.145x -25.98%
2009-06-30 GBX4.83 Million
≈ $587.18
GBX948.00K
≈ $115.34
0.196x +58.43%
2008-06-30 GBX4.32 Million
≈ $525.01
GBX535.00K
≈ $65.09
0.124x -70.70%
2007-06-30 GBX2.63 Million
≈ $319.99
GBX1.11 Million
≈ $135.42
0.423x +163.51%
2006-06-30 GBX2.00 Million
≈ $243.95
GBX322.00K
≈ $39.18
0.161x +0.54%
2005-06-30 GBX1.68 Million
≈ $204.89
GBX269.00K
≈ $32.73
0.160x +110.65%
2004-04-30 GBX-154.00K
≈ $-18.74
GBX231.00K
≈ $28.11
-1.500x --

About Tristel

LSE:TSTL UK Medical Instruments & Supplies
Market Cap
$2.27 Million
GBX18.63 Billion GBX
Market Cap Rank
#29873 Global
#656 in UK
Share Price
GBX387.50
Change (1 day)
-1.27%
52-Week Range
GBX355.00 - GBX450.00
All Time High
GBX617.87
About

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for … Read more